Calendar Structure Therapeutics Inc.

Equities

GPCR

US86366E1064

Market Closed - Nasdaq 21:00:00 24/06/2024 BST 5-day change 1st Jan Change
43.68 USD -4.15% Intraday chart for Structure Therapeutics Inc. -10.09% +7.16%

Chart calendar Structure Therapeutics Inc.

7d5b2070def.qk_y8_4mXVV6LeSJP2nWTVUS4WL377ZzU0aoXjXDQ0M.7X2dsrN3MjYLatHQWluPOBxkqDCowt9LHTHKCEWgEzHdC7mFyH8PbAxoiw~6c207230f10835e62744e4a3606892e3

Upcoming events on Structure Therapeutics Inc.

Today 17:00 Annual General Meeting
07/08/2024 Q2 2024 Earnings Release (Projected)
11/11/2024 Q3 2024 Earnings Release (Projected)
26/03/2025 Q4 2024 Earnings Release (Projected)
07/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Structure Therapeutics Inc.

03/06/2024 13:30 GSBR-1290 Phase 2a Study Results Call
09/05/2024 21:05 Q1 2024 Earnings Release
13/03/2024 12:00 Leerink Partners Global Biopharma Conference
08/03/2024 13:30 Q4 2023 Earnings Release
18/12/2023 13:30 Business Update Call
14/11/2023 21:10 Q3 2023 Earnings Release
29/09/2023 13:30 Business Update Call
10/08/2023 21:05 Q2 2023 Earnings Release
25/06/2023 19:30 American Diabetes Association Scientific Session - Poster No - 760
25/06/2023 19:30 American Diabetes Association Scientific Meeting - Poster No - 754
08/06/2023 14:30 Jefferies Global Healthcare Conference
24/05/2023 17:00 American Thoracic Society International Conference - Poster No: P925
22/05/2023 16:30 American Thoracic Society International Conference - Poster No: P207
21/05/2023 16:30 American Thoracic Society International Conference - Poster No: P1059
11/05/2023 21:30 Q1 2023 Earnings Release
30/03/2023 21:30 Q4 2022 Earnings Release

Annual results

Fiscal PeriodDecember 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-

0,00

EBITDA
Million USD
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-

-162

EBIT
Million USD
Released
Forecast
Spread
0,00


-52,6
-52,6
0.07%
-103
-101
-1.33%

-156

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-51,3
-52,1
1.53%
-89,4
-91,7
2.52%

-145

Net income
Million USD
Released
Forecast
Spread
-38,0


-52,8
-52,4
-0.83%
-89,6
-93,4
4.01%

-132

EPS
USD
Released
Forecast
Spread
-5,38


-5,51
-4,94
-11.54%
-0,81
-0,87
7.32%

-0,92

Announcement Date12/01/2330/03/2308/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00


0,00

EBITDA
Million USD
Released
Forecast
Spread



















-32,0


-47,0


-52,0







EBIT
Million USD
Released
Forecast
Spread
-13,0
-13,0
0.34%
-19,6
-17,7
-11.33%
-26,0
-20,3
-27.73%
-26,1
-26,8
2.38%
-31,0
-26,9
-15.2%
-32,0
-37,0
13.36%

-35,9


-41,6


-50,7


-40,8


-43,4

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-12,1
-12,9
6.55%
-18,0
-16,2
-10.8%
-23,2
-20,0
-15.84%
-23,5
-27,0
13.04%
-24,8
-26,9
7.76%
-26,0
-28,4
8.53%

-33,0


-39,3


-44,1


-40,8


-43,4

Net income
Million USD
Released
Forecast
Spread
-11,9
-13,0
8.65%
-18,0
-16,6
-8.28%
-23,3
-19,0
-22.55%
-23,9
-27,0
11.57%
-24,5
-27,4
10.66%
-26,0
-29,0
10.1%

-32,2


-36,8


-40,9


-40,8


-43,4

EPS
USD
Released
Forecast
Spread
-1,17
-1,10
-6.36%
-0,25
-0,34
25.37%
-0,20
-0,20
0%
-0,21
-0,24
11.27%
-0,16
-0,21
22.89%
-0,19
-0,21
9.52%

-0,23


-0,24


-0,26


-0,26


-0,29

Announcement Date30/03/2311/05/2310/08/2314/11/2308/03/2409/05/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. GPCR Stock
  4. Calendar Structure Therapeutics Inc.